TrialOphthalmology2015

Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Michael M Altaweel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.